VolitionRx (VNRX) Earnings Date, Estimates & Call Transcripts $0.81 +0.14 (+20.90%) (As of 11/20/2024 ET) Add Compare Share Share Earnings Stock AnalysisChartEarningsHeadlinesInsider TradesShort Interest VolitionRx Latest Earnings SummaryLatest Q2 2024 Earnings DateAug. 14EstimatedActual EPS (Aug. 14) -$0.08 Beat By $0.01 Consensus EPS (Aug. 14) -$0.09 VolitionRx released Q2 2024 earnings on August 14, 2024, reporting an EPS of -$0.08, which topped the consensus estimate of -$0.09 by $0.01. Quarterly revenue was reported to be $0.40 million, above analysts' expectations of $0.34 million. With a trailing EPS of -$0.56, VolitionRx's earnings are expected to grow next year, from ($0.50) to ($0.33) per share. Get VolitionRx Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on VolitionRx and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataVNRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VNRX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Claim your FREE book now before it's too late! VolitionRx Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.50) EPSNext Year EPS Consensus Estimate: ($0.33) EPS VolitionRx Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks8/14/2024Q2 2024-$0.09-$0.08+$0.01-$0.08$0.34M$0.40M5/13/2024Q1 2024-$0.11-$0.10+$0.01-$0.10$0.27M$0.17M3/25/2024Q4 2023--$0.11 -$0.11-$0.11$0.50M$0.24M11/14/2023Q3 2023-$0.12-$0.11+$0.01-$0.11$0.26M$0.17M 8/14/2023Q2 2023-$0.13-$0.14 -$0.01-$0.14$0.29M$0.22M 5/10/2023Q1 2023--$0.15 -$0.15-$0.15-$0.15M Get the Latest News and Ratings for VNRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for VolitionRx and its competitors with MarketBeat's FREE daily newsletter. 5/10/2023Q1 2023--$0.15 -$0.15-$0.15-$0.15M5/10/2023Q1 2023--$0.15 -$0.15-$0.15-$0.15M5/10/2023Q1 2023--$0.15 -$0.15-$0.15-$0.15M5/10/2023Q1 2023--$0.15 -$0.15-$0.15-$0.15M5/10/2023Q1 2023--$0.15 -$0.15-$0.15-$0.15M5/10/2023Q1 2023--$0.15 -$0.15-$0.15-$0.15M5/10/2023Q1 2023--$0.15 -$0.15-$0.15-$0.15M5/10/2023Q1 2023--$0.15 -$0.15-$0.15-$0.15M5/10/2023Q1 2023--$0.15 -$0.15-$0.15-$0.15M5/10/2023Q1 2023--$0.15 -$0.15-$0.15-$0.15M5/10/2023Q1 2023--$0.15 -$0.15-$0.15-$0.15M5/10/2023Q1 2023--$0.15 -$0.15-$0.15-$0.15M3/15/2023Q4 2022-$0.15-$0.13+$0.02-$0.13$0.06M$0.12M3/15/2023Q4 2022-$0.15-$0.13+$0.02-$0.13$0.06M$0.12M3/15/2023Q4 2022-$0.15-$0.13+$0.02-$0.13$0.06M$0.12M3/15/2023Q4 2022-$0.15-$0.13+$0.02-$0.13$0.06M$0.12M3/15/2023Q4 2022-$0.15-$0.13+$0.02-$0.13$0.06M$0.12M3/15/2023Q4 2022-$0.15-$0.13+$0.02-$0.13$0.06M$0.12M3/15/2023Q4 2022-$0.15-$0.13+$0.02-$0.13$0.06M$0.12M3/15/2023Q4 2022-$0.15-$0.13+$0.02-$0.13$0.06M$0.12M3/15/2023Q4 2022-$0.15-$0.13+$0.02-$0.13$0.06M$0.12M3/15/2023Q4 2022-$0.15-$0.13+$0.02-$0.13$0.06M$0.12M3/15/2023Q4 2022-$0.15-$0.13+$0.02-$0.13$0.06M$0.12M3/15/2023Q4 2022-$0.15-$0.13+$0.02-$0.13$0.06M$0.12M3/15/2023Q4 2022-$0.15-$0.13+$0.02-$0.13$0.06M$0.12M VolitionRx Earnings - Frequently Asked Questions When did VolitionRx announce their last quarterly earnings? VolitionRx (NYSEAMERICAN:VNRX) last announced its quarterly earning data on Wednesday, August 14, 2024. Learn more on VNRX's earnings history. Did VolitionRx beat their earnings estimates last quarter? In the previous quarter, VolitionRx (NYSEAMERICAN:VNRX) reported ($0.08) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.09) by $0.01. Learn more on analysts' earnings estimate vs. VNRX's actual earnings. How much revenue does VolitionRx generate each year? VolitionRx (NYSEAMERICAN:VNRX) has a recorded annual revenue of $310,000.00. How much profit does VolitionRx generate each year? VolitionRx (NYSEAMERICAN:VNRX) has a recorded net income of -$30.27 million. VNRX has generated -$0.56 earnings per share over the last four quarters. What is VolitionRx's EPS forecast for next year? VolitionRx's earnings are expected to grow from ($0.50) per share to ($0.33) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies INBX Earnings Results AMRN Earnings Results LXEO Earnings Results ACRV Earnings Results NGNE Earnings Results EDIT Earnings Results SLDB Earnings Results XBIT Earnings Results CRBP Earnings Results ENTA Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report DeFi Coin on Verge of Breakout! (Ad)The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Claim your FREE book now before it's too late! This page (NYSEAMERICAN:VNRX) was last updated on 11/20/2024 by MarketBeat.com Staff From Our PartnersTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands...Angel Publishing | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredAmerica’s Pro-Crypto AgendaCash In On the Pro-Crypto America 27 experts reveal their top picks for 2025 Crypto 101 Media | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | SponsoredThe smart-money is buying this US$1 lithium stockLithium is getting white-hot once again! And that means well-timed investors who position now in the best n...Resource Stock Digest | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VolitionRx Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share VolitionRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
